Zentalis Pharmaceuticals to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2025
One poster demonstrating cell-free DNA molecular response as a potential surrogate endpoint to measure clinical efficacy of azenosertib in ...
Monte Rosa Therapeutics announces anticipated upcoming milestones
Continue advancement of MRT-6160 through Phase 2 initiation, in collaboration with Novartis. Share additional MRT-2359 Phase 1/2 study data in ...
American Association of Individual Investors5d
Why Monte Rosa Therapeutics, Inc.’s (GLUE) Stock Is Down 17.85%
Monte Rosa Therapeutics, Inc.’s GLUE share price has dipped by 17.85%, which has investors questioning if this is right time ...
Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript March 20, 2025 Monte Rosa Therapeutics, Inc. beats earnings expectations. Reported EPS is $0 ...
Yahoo Finance2d
Monte Rosa Therapeutics, Inc. (GLUE)
After hours: March 21 at 7:59:41 PM EDT Loading Chart for GLUE ...
Yahoo Finance2d
Incyte Corporation (INCY)
After hours: March 14 at 5:13:30 p.m. EDT Loading Chart for INCY ...
Yahoo Finance5d
Relay Therapeutics, Inc. (RLAY)
After hours: March 21 at 7:27:14 PM EDT Loading Chart for RLAY ...
Frontiers6d
Integration of Computational and Experimental Methods to Discover Natural Metabolites for Treating Various Human Diseases
Computer-Aided Drug Design (CADD) is an area of science that is rapidly growing, involving using computers to discover and design new drugs. CADD focuses on understanding the three-dimensional ...